| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 137813-35-5 | 環(huán)(Arg-Gls-Asp-D-Phe-Val) | Cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-L-valyl); 1,4,7,10,13-Pentaazacyclopentadecane,cyclic peptide deriv.; 1: PN: WO0133218 PAGE: 8 claimed protein; 1: PN:WO2009038243 SEQID: 1 claimed protein; 1: PN: WO2009040071 PAGE: 98 claimedprotein; 3: PN: WO02100883 PAGE: 45 claimed protein; 5: PN: WO0047228 SEQID: 5claimed protein; EMD 66203 |  | C26H38N8O7 | 詳情 | 供應(yīng)商 |
| 153345-76-7 | Cyclo[N2-methyl-L-arginylglycyl-L-a-aspartyl-3-(aminomethyl)benzoyl-D-valyl](9CI); L-Asparticacid, N-[3-(aminomethyl)benzoyl]-D-valyl-N2-methyl-L-arginylglycyl-, cyclic (41® 1)-peptide; 3,6,9,12,15-Pentaazabicyclo[15.3.1]heneicosane, cyclic peptide deriv.; DMP 757 |  | C26H38N8O7 | 詳情 | 供應(yīng)商 |